carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Launch of Generic Strattera
Released: 05/31/2017
By: Heidi Dufrene, PharmD

The generic equivalent of Strattera (Atomoxetine) has just been released, following FDA approval. Strattera is FDA-approved to treat ADHD (Attention deficit hyperactivity disorder). Strattera is available in several strengths, (10, 18, 25, 40, 60, 80 and 100mg) all of which will be available in the generic formulation.

All generic drugs approved by the FDA have the same quality, strength, purity and stability as brand name drugs. The generic manufacturing, packaging and testing sites must pass the same quality standards as those of brand name drugs.

Please contact us at 800-553-1783 or at if you have any questions on this announcement or if our pharmacy staff may assist you in any way.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer